Cargando…
Prior SARS-CoV-2 infection increases reactogenicity after SARS-COV-2 mRNA vaccine and could delay the administration of the vaccine based on timing of infection
Autores principales: | Stellini, Roberto, Gianello, Renzo, Meloni, Angelo, Croce, Elia, Materzanini, Paola, Gomarasca, Walter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8636582/ https://www.ncbi.nlm.nih.gov/pubmed/34855188 http://dx.doi.org/10.1007/s15010-021-01729-z |
Ejemplares similares
-
Durability of anti-spike antibodies after vaccination with mRNA SARS-CoV-2 vaccine is longer in subjects with previous infection: could the booster dose be delayed?
por: Stellini, Roberto, et al.
Publicado: (2022) -
An Analysis of SARS-CoV-2 Vaccine Reactogenicity: Variation by Type, Dose, and History, Severity, and Recency of Prior SARS-CoV-2 Infection
por: Scher, Ann I, et al.
Publicado: (2022) -
Correction to: An Analysis of SARS-CoV-2 Vaccine Reactogenicity: Variation by Type, Dose, and History, Severity, and Recency of Prior SARS-CoV-2 Infection
Publicado: (2022) -
Immunogenicity and reactogenicity of inactivated SARS-CoV-2 vaccines in healthy adults
por: Wu, Yufei, et al.
Publicado: (2023) -
Reactogenicity, SARS-cov-2 infection, and pregnancy outcomes following COVID-19 vaccination during pregnancy in canada
por: E, Mcclymont, et al.
Publicado: (2023)